Which class of medications is recommended to reduce agitation and anxiety in the expectant burn patient?

Which class of medications is recommended to reduce agitation and anxiety in the expectant burn patient?

• A. Benzodiazepines
• B. Antipsychotics
• C. Opioids
• D. Antidepressants

Answer: (A)

When a burn patient is acutely agitated and anxious, you want something that quickly calms nerves and provides safe sedation to allow essential care. Benzodiazepines fit that need best because they enhance GABA’s inhibitory effect in the brain, producing rapid anxiolysis, sedation, and muscle relaxation. This helps with painful wound care, dressing changes, and other procedures by reducing tension and improving cooperation, while also easing sleep and overall comfort. They’re also readily available in IV or PO forms for swift control in acute settings. Other options don’t address anxiety as directly: opioids relieve pain but don’t reliably reduce anxiety; antidepressants take weeks to work; and antipsychotics manage agitation from delirium or psychosis rather than primary anxiety and carry different risk profiles. Use with careful dosing and monitoring for respiratory depression, excessive sedation, and potential delirium, adjusting to the patient’s condition and monitoring needs.

When a burn patient is acutely agitated and anxious, you want something that quickly calms nerves and provides safe sedation to allow essential care. Benzodiazepines fit that need best because they enhance GABA’s inhibitory effect in the brain, producing rapid anxiolysis, sedation, and muscle relaxation. This helps with painful wound care, dressing changes, and other procedures by reducing tension and improving cooperation, while also easing sleep and overall comfort. They’re also readily available in IV or PO forms for swift control in acute settings. Other options don’t address anxiety as directly: opioids relieve pain but don’t reliably reduce anxiety; antidepressants take weeks to work; and antipsychotics manage agitation from delirium or psychosis rather than primary anxiety and carry different risk profiles. Use with careful dosing and monitoring for respiratory depression, excessive sedation, and potential delirium, adjusting to the patient’s condition and monitoring needs.